Countries fail to reach a compromise in TPP talks

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Countries fail to reach a compromise in TPP talks

After four days of negotiations, international delegates from 12 countries have failed to reach a compromise over the Trans Pacific Partnership (TPP) Agreement.

The Office of the United States Trade Representative issued a statement yesterday claiming that "substantial progress" has been made in the TPP talks, which are now expected to continue into next year.

The news follows Monday's release by whistleblowing site WikiLeaks of two documents that suggest the US is isolated in its positions on many issues including intellectual property, and is exerting "great pressure" on other countries to comply with its demands.

One of the documents, an internal memo, records "large differences that continue in most areas of the chapter" on intellectual property. It recounts the meeting chair recording solutions "coming from the US position", prompting other countries to demand corrections to the text, which could later be used by the US as a basis for reaching an agreement.

The memo also describes the US proposals on Investor State Dispute Settlement, which allow companies to directly sue governments at a secret international arbitration tribunal, as one of "one of the most significant barriers to closing the chapter" on investment.

The other document, a spreadsheet outlining the positions of the countries on the various issues, shows the US as the sole supporter of proposals such as linkage requirements for pharmaceuticals, the criminalisation of copyright infringement and rules against parallel importation, which was judged to be legal by its own Supreme Court in Kirtsaeng v John Wiley.

The countries involved in the TPP negotiations are Australia, New Zealand, the US, Peru, Chile, Mexico, Canada, Singapore, Brunei, Malaysia, Japan and Vietnam.

Yesterday, six members of US Congress wrote to President Barack Obama arguing that the "secret" negotiations benefit pharmaceutical companies at the expense of public health. The writers, all Democrats, urged the president not to make any final trade agreements "that affect critical health issues" until politicians and members of the public have had the opportunity to review and comment on the proposals.

Joseph Stiglitz, a Nobel prize-winning economist from the Columbia University School of Business, has also written to the negotiators, arguing that several of the proposals would weaken the 2001 Doha Declaration on TRIPS and Public Health.

Separately, 27 organisations and over 70 individuals have signed on to a letter by Knowledge Ecology International protesting the proposal to extend copyright protection to life plus 70 years. The letter argues the extension will result in the loss of countless owned but uncommercialised works and will be "costly to consumers and performers, while benefiting persons and corporate owners that had nothing to do with the creation of the work."

more from across site and SHARED ros bottom lb

More from across our site

Partner Rob Jacob unveils plans to offer a beginning-to-end trademark service, how to make prosecution profitable, and why IP ‘buy-in’ from the CEO stands the firm in good stead
Sponsored by CAS
CAS provides practical pointers on how intellectual property and R&D teams can work in tandem to unlock tangible benefits and avoid wasted spend
Sponsored by CAS
CAS explores how AI is transforming intellectual property, from inventorship and copyright disputes to new demands on patent attorneys
Sponsored by That.Legal
Gillian Tan of That.Legal discusses a recent decision by the Intellectual Property Office of Singapore and what it reveals about the evidential burden in bad-faith trademark claims
Attorneys at Di Blasi, Parente & Associados share how the protection of trade secrets strengthens innovation by bringing together legal practice, regulatory developments, and established international references
Jin Ooi, who joins as a partner today, said he is excited to offer a ‘rounded’ IP service as the firm deepens its litigation expertise in the UK and Europe
As generics celebrate, practitioners believe innovator companies should brace for an ‘uphill battle’ when trying to prove induced infringement
A team from Cooley shares how they overturned a massive damages award by emphasising that the opposing company’s trade secrets claims were time-barred
Sponsored by Licks Attorneys
Eduardo Hallak, Rafaella Oliveira, and Laís Souza of Licks Attorneys explain how the provision operates in practice, highlighting evidential hurdles and best practices for patent applicants
Sponsored by Liu, Shen & Associates
Chunyu Cui and Ziqing Wu of Liu, Shen & Associates say recent trends in China’s intellectual property courts indicate alignment with international standards and send a clear signal to the global market
Gift this article